Drug Trial Radar · NCT01573403
Efficacy and Safety of DLBS2411 in Healthy Volunteers
Last checked: Nov 19, 2026Latest source record: Feb 13, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
54
Actual
Start
Apr 2012
Primary completion
Dec 2012
Study completion Jan 2013
Sponsor
- Lead sponsor
- Dexa Medica GroupIndustry
- Sponsor type
- Industry
- First posted
- Apr 9, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a 3-arm, double-blind, randomized, controlled, parallel and dose ranging clinical study for 3 days of therapy to investigate the effect of DLBS2411 in gastric pH regulation as well as its safety in healthy volunteers. DLBS2411 has similar mechanism of action with proton-pump inhibitors (PPIs). However, it is hypothetically more potential than PPIs in suppressing gastric acid as our previous preclinical studies with DLBS2411 have proven its effects not only on the activity of H+/K+ ATPase, the enzyme that regulates proton pump in stomach, but also on its gene expression. It is hypothesized that DLBS2411 may benefit on gastric pH regulation in healthy volunteers.
Conditions
- Gastric pH Regulation in Healthy Volunteers
Interventions
DLBS2411Drug
1 caplet of DLBS2411 @250 mg and 1 placebo caplet, once daily
DLBS2411Drug
2 caplets of DLBS2411 @250 mg, once daily
Placebo DLBS2411Drug
2 placebo caplets of DLBS2411, once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of time over 24 hours during which gastric pH is > 4Time frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Division of Gastroenterology, Department of Internal Medicine, dr. Cipto Mangunkusumo Hospital
Jakarta Center, Jakarta Special Capital Region, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.